The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review [0.03%]
拥有较长国民医疗服务体系等待名单的择期手术程序的成本效益：一项定向回顾研究
Laura A Trigg,Caroline Farmer,Madhusubramanian Muthukumar et al.
Laura A Trigg et al.
Objectives: Our aim was to review the evidence for the cost effectiveness of elective surgeries with long waiting lists within the NHS in England. This is to inform understanding of national spending priorities in the con...
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China [0.03%]
在中国ASCVD患者中他汀单药治疗与联合使用依洛尤单抗或 inclisiran 的成本效果分析
Pengpeng Wang,Le Liang,Yamei Li
Pengpeng Wang
Background and objective: Several innovative proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been approved for combination lipid-lowering therapy in China. Compared with their high initial launch pri...
Evaluating Access Improving Interventions: An Economic Evaluation of Surgical Task-Shifting for C-Sections in Sierra Leone [0.03%]
评价改善获取途径的措施：经济评估塞拉利昂剖宫产手术的任务移转政策的影响
Bryony Dawkins,Bethany Shinkins,Tim Ensor et al.
Bryony Dawkins et al.
Background: Access to safe, timely and affordable surgical care is lacking globally. Less than 6% of all surgical operations are carried out in low- and middle-income countries, where over a third of the world's populatio...
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value [0.03%]
基因技术的卫生经济学：关于价值的证据正在不断积累
James Buchanan,Ilias Goranitis,Deirdre Weymann
James Buchanan
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil [0.03%]
巴西用于治疗血栓性血小板减少性紫癜的Caplacizumab的成本效益和信息价值分析
Julia Simões Correa Galendi,Hannes Rasch,Carlos Antonio Caramori et al.
Julia Simões Correa Galendi et al.
Objectives: The objective was to evaluate the cost effectiveness of caplacizumab for the treatment of patients with acquired immune thrombocytopenic thrombotic purpura (iTTP) compared to standard of care from the perspect...
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences [0.03%]
强制许可作为应对高药价工具的实证主义评价：工业和卫生影响回顾
Steven Simoens,Walter Van Dyck,Rosanne Janssens et al.
Steven Simoens et al.
Although compulsory licensing of medicines is traditionally discussed in the context of low- and middle-income countries tackling high prices, it has recently sparked debate in several high-income countries. This study aims to examine the i...
Measurement Properties of the EQ-5D Instruments in Children and Adolescents: A Systematic Review [0.03%]
儿童和青少年EQ-5D量表测量属性的系统评价
Caique de Melo do Espirito Santo,Verônica Souza Santos,Alessandro Chiarotto et al.
Caique de Melo do Espirito Santo et al.
Background: The EQ-5D instruments have been widely used to measure health-related quality of life (HRQoL) in child and adolescent populations, especially the EQ-5D-Y-3L and EQ-5D-Y-5L (beta version). Although not specific...
Decision-Analytical Modelling of Medicines in the Middle East: A Systematic Review of Economic Evaluation Studies [0.03%]
中东地区药品决策分析模型：系统评价研究
Zainab Abdali,Tuba Saygın Avşar,Sue Jowett et al.
Zainab Abdali et al.
Background: Economic evaluations through decision-analytical models have played a limited role in shaping healthcare resource optimisation and reimbursement decisions in the Middle East. ...
Financial Viability of Private Hospitals Operating Under India's National Health Insurance Scheme Ayushman Bharat Pradhan Mantri-Jan Arogya Yojana (AB PM-JAY) [0.03%]
印度国家健康保险方案Ayushman Bharat Pradhan Mantri-Jan Arogya Yojana (AB PM-JAY)下私营医院的财政可行性研究
Gaurav Jyani,Praveen Gedam,Sameer Sharma et al.
Gaurav Jyani et al.
Background: Private hospitals account for 46% of all hospitals empanelled in India's national health insurance scheme and contribute to 54% of all the hospitalizations under it. However, insufficient package prices are of...
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making [0.03%]
指引卫生资源分配：使用人口净健康效益使疾病负担与成本效益一致以进行知情决策
Megha Rao,Simon Walker,Karl Claxton et al.
Megha Rao et al.
Limited healthcare resources necessitate a strategic approach to their allocation. This paper highlights the importance of population net health benefit (NHB) metric as a means of aligning two existing concepts used for resource prioritizat...